About MEMS   |   Council   |   Members Centre   |   Membership   |   Contact Us   |   Home
  Member Login     username:     password:           Forgot your password?
  Home » CPG » 
Presidentís Message
The Endocrine Directory
Calendar of Events
Announcements & Updates
Breaking News & Reports
In the Press
Disease Areas
Healthy Lifestyle
Research Programs
Photo & Video Gallery
Useful Links
Disease Management

24 June 2009

 Guideline Development and Objective

The guideline development task force consisted of endocrinologist, a nephrologist, an ophthalmologist. Two family medicine specialists, a general physician, a neurologist, a paediatric endocrinologist, two public health physicians, a dietitian and a diabetic nurse educator.

The previous edition of the CPG for Management of T2DM (2004) was used as the basis for the development of this present guideline.

Literature search was carried out at the following electronic databases: PUBMED, Medline Cochrane Databases of Systemic Reviews (CDSR), Journal full text via OVID search engine. In addition, the reference lists of all relevant articles retrieved were searched to identify further studies.

Reference was also made to other guidelines on the management of T2DM including American Diabetes Association (ADA), Position Statement on Standards of  Medical Care in Diabetes, 2008; American Association of Clinical Endriconologists (AACE) Medical Guidelines for Clinical Practice for the Management of Diabetes Mellitus, 2007; International Diabetes Federation  (IDF), Global Guideline for type 2 Diabetes, 2005; American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD), Management of Hyperglycaemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Theraphy, 2006; Malaysian CPG on Management of Obesity 2004; Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada; Medical Nutrition Theraphy Guidelines for type 2 Diabetes, Malaysian Dietitian Association, 2005.

This guideline is based largely on the findings of systemic reviews and meta-analyses in the literature, taking into consideration local practices.

The clinical questions were divided into major subgroups and members of the task force were assigned individual topics within these subgroups. The task force met a total of 9 times throughout the development of the guideline. All literature retrieved were critically appraised, presented and discussed during group meetings. All statements and recommendations formulated were agreed by the task force members. Where the evidence was insufficient, the recommendations were derived by consensus of the task force members.

The articles were graded using the criteria used by the United Stated/Canadian Preventive Service Task Force, while the grading of recommendations in this guideline was modified from the Scottish Intercollegiate Guidelines Network (SIGN).

 For further reading, please download the CPG below...

  arrowCPG T2DM 2009 (English - pdf - 626 Kb)

  printer Printer-friendly version   printer Send link to a friend

| | | |
© Copyright Malaysian Endocrine & Metabolic Society (MEMS)   2009 - 2016    All rights reserved.
designed & maintained: mobition